Which Zinc Form is Best for Eye Vitamins?

Periodically, we get an inquiry from a customer asking why VisIVite uses Zinc oxide rather than some other form in its AREDS 2 eye vitamins. And usually, the question is asked because they were told by a dietition, nutritionist or salesperson in a supplement store that other forms of zinc are better and more completely […]

Gene therapy treatment for AMD in clinical trials

Phase 1 clinical trials on a new gene therapy to treat age-related macular degeneration are currently underway in multiple locations around the country. Early results from the trials are offering promising results and researchers hope gene therapy for wet macular degeneration will be available within the next 3 to 5 years. This new therapy would […]

New Drug for Dry Macular Degeneration?

A new drug to treat the “dry” form of macular degeneration is currently undergoing clinical trials. Allegro Ophthalmics has reported encouraging results from the phase 2 study of Risuteganib. The small phase 2 study involved 40 patients and was conducted over a 28 week period with participants receiving 2 injections. Half of the patients received […]

New Drug Approved for Wet Macular Degeneration

Novartis Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved it’s new drug, Beovu®, for the treatment of wet age-related macular degeneration (AMD). Beovu® (brolucizumab) recently completed two late-stage clinical trials, which tested the safety and efficacy of the intravitreal injection. Wet AMD is an eye condition which can lead to a […]

Which Sunglasses Best Protect Your Vision?

While sunglasses are often deemed to be no more than a fashion accessory, the impact that they have on your vision is critically important. The choice of your sunglasses is every bit as important as your choice of sun block for your skin. The National Eye Institute reports that UV radiation can damage proteins in […]

Air pollution a factor in macular degeneration

Study results recently published in the Journal of Investigative Medicine point to a link between air pollutants and an increased risk of developing age-related macular degeneration. This is the first study to show a notable association between macular degeneration and high levels of atmospheric pollution. The study was conducted in Taiwan and involved tracking levels […]

Medication for Dry Macular Degeneration Coming Soon?

While Wet Macular Degeneration has enjoyed the fruits of great research and effective medications, the more common Dry Macular Degeneration has no similar medications for treatment. That might be changing soon. The company, Allegro Ophthalmics, LLC, has developed the molecule, Risuteganib, which the company states is effective against the oxidative stress in the retina that […]

What the Doctor is Doing – Issue 1

Sometimes it’s nice to hear from the doctor himself about what he’s doing for his own overall health and eye health. After all, does he practice what he preaches?

New implant delivers medicine continuously to eye

The current therapy for treating wet macular degeneration involves costly, frequent injections into the eye. Researchers are currently working on a new therapy that involves putting an implant into the eye that would continuously deliver the medication into the eye. Injection therapy only offers temporary help in preserving central vision with wet macular degeneration and […]

Donor Cells Implanted for Macular Degeneration

Researchers at the Riken Institute in Japan completed the first clinical trial involving the transplantation of induced pluripotent stem cells (iPS cells) from donors. Five patients received the donated cells. Artificially grown retinal cells were made from donor iPS cells and were used to treat the patients suffering from wet age-related macular degeneration. The first […]